Delivery Order SPE2DB20D1100-SPE2DB25FE4X6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a contract ceiling value of $1,661.91. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, represents a non-set-aside competitive award to support federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyvanse 20 mg capsules (100 count) with a ceiling value of $1,438.26. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and was awarded competitively with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a ceiling value of $2,761.55 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,139.08 for Vyvanse 10 mg capsules (100-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-competitive delivery order represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. The award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse 10 mg capsules (100 count) under contract number 4569458763. The order, valued at $14,907.14, carries a firm fixed price and is scheduled for completion by September 15, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $11,906.43 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100-count units) under a firm fixed-price contract. The delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a competitive award with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,241.46 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 70 mg capsules (100-count units) with a contract ceiling value of $1,440.16. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a contract value of $1,337.70. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4X6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,173.62 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100 count) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The contract supports various federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's critical role as a major pharmaceutical distributor for Department of Defense medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/5/25 |